Arcutis Biotherapeutics, Inc. (ARQT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 438.06M | 411.23M | 349.22M | 332.78M | 323.67M | 335.82M | 423.72M | 434.59M | 468.06M | 330.43M | 281.55M | 308.87M |
| Cash & Short-Term Investments | 224M | 220.98M | 191.07M | 191.13M | 198.09M | 227.96M | 330.56M | 363.05M | 404.48M | 271.86M | 227.11M | 268.67M |
| Cash Only | 34.76M | 42.91M | 47.12M | 73.05M | 53.1M | 71.33M | 134.85M | 84.89M | 190.71M | 88.4M | 107.47M | 105.11M |
| Short-Term Investments | 189.24M | 178.07M | 143.95M | 118.08M | 144.98M | 156.62M | 195.71M | 278.17M | 213.77M | 183.46M | 119.64M | 163.56M |
| Accounts Receivable | 144.38M | 146.23M | 115.12M | 106.69M | 85.42M | 73.07M | 60.12M | 43.41M | 37.15M | 25.81M | 19.42M | 17.21M |
| Days Sales Outstanding | 124.08 | 92.83 | 102.83 | 107.24 | 108.31 | 85.85 | 106.41 | 118.79 | 57.79 | 153.8 | 44.21 | 262.8 |
| Inventory | 37.39M | 22.63M | 22.42M | 16.32M | 16.61M | 14.53M | 14.02M | 13.88M | 13.25M | 13.13M | 13.91M | 10.47M |
| Days Inventory Outstanding | 276.08 | 177.31 | 205.2 | 200.04 | 158.7 | 190.14 | 233.18 | 356.32 | 368.65 | 553.95 | 949.07 | 1.12K |
| Other Current Assets | 32.29M | 21.39M | 9.71M | 7.74M | 11.85M | 8.82M | 19.02M | 3.15M | 617K | 9.53M | 925K | 3.09M |
| Total Non-Current Assets | 21.95M | 21.74M | 21.75M | 19.65M | 20.43M | 13.07M | 13.63M | 10.17M | 10.48M | 10.93M | 11.41M | 11.82M |
| Property, Plant & Equipment | 5.4M | 5.51M | 5.78M | 3.12M | 3.34M | 2.99M | 3.25M | 3.51M | 3.63M | 3.9M | 4.19M | 4.41M |
| Fixed Asset Turnover | 19.32x | 22.94x | 22.29x | 25.23x | 20.80x | 22.87x | 13.25x | 8.64x | 13.16x | 3.34x | 8.86x | 1.14x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 14.25M | 14.81M | 15.38M | 15.94M | 16.5M | 9.48M | 9.79M | 6.06M | 6.25M | 6.44M | 6.63M | 6.81M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.3M | 1.42M | 596K | 596K | 596K | 596K | 596K | 595K | 596K | 596K | 596K | 596K |
| Total Assets | 460M | 432.97M | 370.98M | 352.43M | 344.11M | 348.89M | 437.35M | 444.76M | 478.54M | 341.37M | 292.96M | 320.69M |
| Asset Turnover | 0.24x | 0.32x | 0.27x | 0.23x | 0.19x | 0.18x | 0.10x | 0.07x | 0.12x | 0.04x | 0.12x | 0.01x |
| Asset Growth % | 33.68% | 24.1% | -15.18% | -20.76% | -28.09% | 2.2% | 49.29% | 38.69% | 26.11% | -24.02% | -42.43% | 6.73% |
| Total Current Liabilities | 163.2M | 129.84M | 99.77M | 103.94M | 91.13M | 81.01M | 172.43M | 51.35M | 47.31M | 46.67M | 41.89M | 36.66M |
| Accounts Payable | 18.3M | 12.53M | 5.79M | 15.08M | 24.53M | 14.22M | 19.32M | 7.94M | 12.97M | 11.99M | 13.18M | 17.16M |
| Days Payables Outstanding | 141.77 | 72.11 | 110.57 | 240.56 | 197.48 | 223.47 | 227.94 | 274.68 | 348.81 | 515.52 | 1.18K | 1.74K |
| Short-Term Debt | 7.95M | 1M | 1M | 1M | 0 | 0 | 99.51M | 777K | 0 | 0 | 715K | 695K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 136.96M | 116.31M | 18.3M | 75.53M | 9.16M | 20.75M | 52.79M | 31.84M | 0 | 19.07M | 13.54M | 9.16M |
| Current Ratio | 2.68x | 3.17x | 3.50x | 3.20x | 3.55x | 4.15x | 2.46x | 8.46x | 9.89x | 7.08x | 6.72x | 8.43x |
| Quick Ratio | 2.46x | 2.99x | 3.28x | 3.04x | 3.37x | 3.97x | 2.38x | 8.19x | 9.61x | 6.80x | 6.39x | 8.14x |
| Cash Conversion Cycle | 258.38 | 198.03 | 197.46 | 66.72 | 69.53 | 52.52 | 111.65 | 200.43 | 77.64 | 192.22 | -187.27 | -359.66 |
| Total Non-Current Liabilities | 107.15M | 113.66M | 113.13M | 109.52M | 110.32M | 110.33M | 108.29M | 206.98M | 206.29M | 206.03M | 204.35M | 203.52M |
| Long-Term Debt | 5.25M | 5.27M | 107.5M | 107.05M | 107.62M | 107.2M | 105.09M | 203.81M | 202.8M | 201.8M | 200.78M | 199.77M |
| Capital Lease Obligations | 0 | 0 | 5.28M | 2.11M | 2.34M | 2.56M | 2.77M | 2.98M | 3.18M | 3.38M | 3.57M | 3.75M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 101.9M | 108.39M | 360K | 360K | 360K | 570K | 420K | 194K | 306K | 849K | 0 | 0 |
| Total Liabilities | 270.36M | 243.49M | 212.9M | 213.46M | 201.45M | 191.35M | 280.71M | 258.33M | 253.6M | 252.7M | 246.24M | 240.18M |
| Total Debt | 13.2M | 6.27M | 113.77M | 110.16M | 110.8M | 110.58M | 208.18M | 207.56M | 206.74M | 205.92M | 205.07M | 204.22M |
| Net Debt | -21.56M | -36.64M | 66.65M | 37.12M | 57.7M | 39.25M | 73.33M | 122.68M | 16.03M | 117.52M | 97.6M | 99.1M |
| Debt / Equity | 0.07x | 0.03x | 0.72x | 0.79x | 0.78x | 0.70x | 1.33x | 1.11x | 0.92x | 2.32x | 4.39x | 2.54x |
| Debt / EBITDA | - | 0.32x | 12.52x | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | -1.86x | 7.33x | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.08x | 6.95x | 3.44x | -4.13x | -7.31x | -0.89x | -5.24x | -5.99x | -3.69x | -7.54x | -4.52x | -8.66x |
| Total Equity | 189.65M | 189.48M | 158.07M | 138.97M | 142.66M | 157.54M | 156.64M | 186.43M | 224.94M | 88.67M | 46.72M | 80.51M |
| Equity Growth % | 32.94% | 20.27% | 0.91% | -25.45% | -36.58% | 77.68% | 235.3% | 131.56% | 60.98% | -57.69% | -82.75% | -58.79% |
| Book Value per Share | 1.47 | 1.40 | 1.19 | 1.09 | 1.13 | 1.30 | 1.26 | 1.51 | 2.03 | 0.96 | 0.76 | 1.31 |
| Total Shareholders' Equity | 189.65M | 189.48M | 158.07M | 138.97M | 142.66M | 157.54M | 156.64M | 186.43M | 224.94M | 88.67M | 46.72M | 80.51M |
| Common Stock | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 9K | 6K | 6K |
| Retained Earnings | -1.15B | -1.14B | -1.16B | -1.16B | -1.15B | -1.12B | -1.11B | -1.07B | -1.02B | -981.9M | -915.62M | -870.86M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -514K | -44K | -62K | -35K | -140K | -7K | 533K | -294K | -133K | 4K | -184K | -292K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |